Medtronic plc
$102.88
+0.02 (+0.02%) · delayed · Nov 16, 2026
Five-year price
52w $73.31 to $106.33
- Market cap
- $131.6B
- Enterprise value
- $157.6B
- P/E
- 27.6×
- 30.6× on 3y avg EPS
- EV / EBIT
- 24.4×
- FCF yield
- 4.1%
- ROIC
- 6.8%
- Debt / equity
- 0.57
- Piotroski F
- 7/9
Value scorecard · FY2026
Does it pass the value tests?
Quality
- ○ROIC > 12% (5y avg)5y avg ROIC 6.2%
- ○ROE > 15% (5y avg)5y avg ROE 8.7%
- ●Stable operating marginsMargin volatility 0.8% (σ, 5y)
- ●Earnings convert to cashFCF / net income 121% (5y avg)
- ●Growing revenueRevenue CAGR 5y 3.8%
- ●Shrinking share countDiluted shares -4.9% over 5y
Value
- ○P/E below 15P/E 27.6
- ○EV/EBIT below 12EV/EBIT 24.4
- ○FCF yield above 6%FCF yield 4.1%
- ○Price below Graham NumberGraham Number $56.97
- ●P/B below 3P/B 2.7
Safety
- ○Debt / equity below 0.5D/E 0.57
- ○Debt payable in < 4 yrs of earningsNet debt $26.0B
- ●Interest coverage > 8xCoverage 9.0x
- ●Current ratio > 1.5Current ratio 2.13
- ●Piotroski F-score ≥ 6F-score 7/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $36.4B
- ●Strong condition (current ratio ≥ 2)Current ratio 2.13
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth 18%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 30.6
- ○P/E × P/B ≤ 22.5Product 81.3
Valuation lab
What do you have to believe?
At $102.88, the market is pricing in about 10.6% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt $26.0B · 1279M shares · 5y revenue CAGR 3.8%
Intrinsic value
$54.55
Price
$102.88
Premium paid
89%
What the price implies
The market is paying for 10.6% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
56% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29,710 | 29,953 | 30,557 | 28,913 | 30,117 | 31,686 | 31,227 | 32,364 | 33,537 | 36,364 |
| Gross profit | 20,419 | 20,898 | — | — | — | — | — | — | — | — |
| Operating income | 5,383 | 6,640 | 6,268 | 4,791 | 4,484 | 5,752 | 5,485 | 5,144 | 5,955 | 6,467 |
| Operating margin | 18.1% | 22.2% | 20.5% | 16.6% | 14.9% | 18.2% | 17.6% | 15.9% | 17.8% | 17.8% |
| Pre-tax income | 4,602 | 5,675 | 5,197 | 4,055 | 3,895 | 5,517 | 5,364 | 4,837 | 5,628 | 6,136 |
| Income tax | 578 | 2,580 | 547 | (751) | 265 | 456 | 1,580 | 1,133 | 936 | 1,299 |
| Net income | 4,028 | 3,104 | 4,631 | 4,789 | 3,606 | 5,039 | 3,758 | 3,676 | 4,662 | 4,801 |
| EPS (diluted) | 2.89 | 2.27 | 3.41 | 3.54 | 2.66 | 3.73 | 2.82 | 2.76 | 3.61 | 3.73 |
| Diluted shares | 1,391 | 1,368 | 1,358 | 1,351 | 1,354 | 1,351 | 1,333 | 1,330 | 1,290 | 1,288 |
Who owns it